Laparoscopic vs. Open nephrectomy for inflammatory renal conditions: a meta-analysis emphasizing safety

腹腔镜肾切除术与开腹肾切除术治疗炎症性肾脏疾病:一项强调安全性的荟萃分析

阅读:1

Abstract

PURPOSE: Nephrectomy for inflammatory renal conditions (IRCs) presents comparable challenges irrespective of the surgical approach. This meta-analysis evaluates whether laparoscopic nephrectomy (LN) is safer than open nephrectomy (ON) for managing IRCs, including xanthogranulomatous pyelonephritis (XGP), pyonephrosis, and renal tuberculosis. METHODS: Following PRISMA/Cochrane guidelines, we systematically reviewed studies comparing LN and ON in adults with IRCs. Inclusion required direct LN vs. ON comparisons and perioperative outcomes. Exclusions included pediatric cohorts and studies conflating converted LN cases with ON groups. RESULTS: From 16 identified studies, 13 met the inclusion criteria, encompassing 868 patients undergoing nephrectomy for IRCs. Of these, 398 (45.9%) underwent ON, and 470 (54.1%) underwent LN. Compared to ON, LN demonstrated a statistically significant (28%) reduction in overall-complications (RR = 0.72, 95% CI [0.6-0.86]; p = 0.0004; low-heterogeneity) and non-significant reduction in high-grade complications (RR = 0.65, 95% CI [0.4-1.06]; p = 0.09; low-heterogeneity), with moderate certainty of evidence. LN was also associated with 53% fewer blood transfusions (post-sensitivity analysis (RR = 0.47, p < 0.0001; low certainty), significant blood loss reduction in XGP-patients (after subgroup analyses MD = -130.8 mL; 95% CI [-203.35 to -58.21]; low certainty), and shorter hospital stays (PMD = -3.04 days; p < 0.00001; very low certainty), albeit with longer operative times (PMD = + 39.05 min; p = 0.03; very low certainty). CONCLUSION: LN is a safer alternative to ON for IRCs, offering fewer complications, shorter hospitalization, and reduced transfusions despite prolonged operative times. Surgeon expertise and patient-specific selection are critical to optimizing outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。